A Phase IIb Efficacy Trial of Ciclosporin (NeuroSTAT) for Moderate to Severe Traumatic Brain Injuries (TBI).
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Ciclosporin (Primary)
- Indications Brain injuries
- Focus Proof of concept; Registrational; Therapeutic Use
- Sponsors NeuroVive Pharmaceutical
- 15 Feb 2018 According to a NeuroVive Pharmaceuticals media release, the proceeds from a successful Rights issue will be used for clinical development and start of this trial in 2018.The company also expects to engage partners and/or receive additional non-diluting funding for this trial
- 21 Sep 2017 According to a NeuroVive Pharmaceutical AB media release, the EMA Scientific Advice feedback is supportive of the novel design of this trial.
- 07 Apr 2014 New trial record